The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: A high-risk combination

American Journal of Kidney Diseases

Volumn 45, Issue 1, 2005, Pages 223-232

  Menon, Vandana ^a   Sarnak, Mark J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease; Chronic kidney disease; epidemiology

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE REPORT; CHRONIC KIDNEY DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; DYSLIPIDEMIA; ECONOMIC ASPECT; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LABORATORY TEST; METABOLIC SYNDROME X; MICROALBUMINURIA; PHYSICAL EXAMINATION; QUALITY OF LIFE; RISK FACTOR; SMOKING HABIT; UNITED STATES;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RISK ASSESSMENT;

EID: 11144294677     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.022     Document Type: Article

References (93)

1. R.N. Foley, P.S. Parfrey, M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 suppl 12 1998 S16 S23
2. R.N. Foley Clinical epidemiology of cardiac disease in dialysis patients Left ventricular hypertrophy, ischemic heart disease, and cardiac failure Semin Dial 16 2003 111 117
3. L.F. Fried, M.G. Shlipak, C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 2003 1364 1372
4. G. Manjunath, H. Tighiouart, H. Ibrahim Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 2003 47 55
5. P. Jungers, Z.A. Massy, T.N. Khoa Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients A prospective study Nephrol Dial Transplant 12 1997 2597 2602
6. A.V. Chobanian, G.L. Bakris, H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 report JAMA 289 2003 2560 2572
7. L. Mosca, L.J. Appel, E.J. Benjamin Evidence-based guidelines for cardiovascular disease prevention in women Circulation 109 2004 672 693
8. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 2003 2154 2169
9. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S246
10. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease Am J Kidney Dis 43 suppl 1 2004 S1 S290
11. US Renal Data System USRDS 1998 Annual Data Report 1998 The National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
12. US Renal Data System USRDS 2003 Annual Data Report 2003 The National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
13. P. Muntner, J. Coresh, N.R. Powe, M.J. Klag The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease J Am Soc Nephrol 14 2003 1568 1577
14. L.G. Hunsicker The consequences and costs of chronic kidney disease before ESRD J Am Soc Nephrol 15 2004 1363 1364
15. D.H. Smith, C.M. Gullion, G. Nichols, D.S. Keith, J.B. Brown Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population J Am Soc Nephrol 15 2004 1300 1306
16. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
17. C.Y. Hsu, F. Lin, E. Vittinghoff, M.G. Shlipak Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States J Am Soc Nephrol 14 2003 2902 2907
18. D.E. Weiner, H. Tighiouart, M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality A pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
19. M.J. Sarnak, A.S. Levey Cardiovascular disease and chronic renal disease A new paradigm Am J Kidney Dis 35 suppl 4 2000 S117 S131
20. P.W. Wilson, R.B. D'Agostino, D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
21. J.C. Longenecker, J. Coresh, N.R. Powe Traditional cardiovascular disease risk factors in dialysis patients compared with the general population The CHOICE Study J Am Soc Nephrol 13 2002 1918 1927
22. M.J. Sarnak, B.E. Coronado, T. Greene Cardiovascular disease risk factors in chronic renal insufficiency Clin Nephrol 57 2002 327 335
23. B.L. Kasiske, H.A. Chakkera, J. Roel Explained and unexplained ischemic heart disease risk after renal transplantation J Am Soc Nephrol 11 2000 1735 1743
24. A.K. Cheung, M.J. Sarnak, G. Yan Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Kidney Int 58 2000 353 362
25. K. Uhlig, A.S. Levey, M.J. Sarnak Traditional cardiac risk factors in individuals with chronic kidney disease Semin Dial 16 2003 118 127
26. M.J. Landray, J. Thambyrajah, F.J. McGlynn Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment Am J Kidney Dis 38 2001 537 546
27. P. Muntner, L.L. Hamm, J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
28. B.P. Oberg, E. McMenamin, F.L. Lucas Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 2004 1009 1016
29. D.C. Wheeler, J.N. Townend, M.J. Landray Cardiovascular risk factors in predialysis patients Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study Kidney Int Suppl 84 2003 S201 S203
30. L.J. Appel Beyond (or back to) traditional risk factors Preventing cardiovascular disease in patients with chronic kidney disease Ann Intern Med 140 2004 60 61
31. E. Ritz, W.M. McClellan Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences J Am Soc Nephrol 15 2004 513 516
32. T. Pinkau, K.F. Hilgers, R. Veelken, J.F. Mann How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease? J Am Soc Nephrol 15 2004 517 523
33. M.G. Shlipak, L.F. Fried, C. Stehman-Breen, D. Siscovick, A.B. Newman Chronic renal insufficiency and cardiovascular events in the elderly Findings from the Cardiovascular Health Study Am J Geriatr Cardiol 13 2004 81 90
34. G. Manjunath, H. Tighiouart, J. Coresh Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney Int 63 2003 1121 1129
35. R.M. Henry, P.J. Kostense, G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality The Hoorn Study Kidney Int 62 2002 1402 1407
36. P. Muntner, J. He, L. Hamm, C. Loria, P.K. Whelton Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 2002 745 753
37. J.S. Jensen, K. Borch-Johnsen, G. Jensen, B. Feldt-Rasmussen Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria Atherosclerosis 112 1995 245 252
38. H.L. Hillege, W.M.T. Janssen, A.A.A. Bak Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity J Intern Med 249 2001 519 526
39. J.I. Barzilay, D. Peterson, M. Cushman The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension The Cardiovascular Health Study Am J Kidney Dis 44 2004 25 34
40. M. Matsagoura, E. Andreadis, E.J. Diamantopoulos Carotid intima-media thickness in patients with type 2 diabetes The significance of microalbuminuria and different risk factors for atherosclerosis Diabetes Care 26 2003 2966
41. H. Yokoyama, T. Aoki, M. Imahori, M. Kuramitsu Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity Kidney Int 66 2004 448 454
42. P. Clausen, J.S. Jensen, G. Jensen, K. Borch-Johnsen, B. Feldt-Rasmussen Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects Circulation 103 2001 1869 1874
43. G.F. Diercks, A.J. van Boven, H.L. Hillege Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study Eur Heart J 21 2000 1922 1927
44. H.C. Gerstein, J.F. Mann, Q. Yi Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426
45. K. Wachtell, H. Ibsen, M.H. Olsen Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy The LIFE study Ann Intern Med 139 2003 901 906
46. H.L. Hillege, V. Fidler, G.F.H. Diercks Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777 1782
47. R. Pedrinelli, O. Giampietro, F. Carmassi Microalbuminuria and endothelial dysfunction in essential hypertension Lancet 344 1994 14 18
48. P. Hovind, L. Tarnow, P. Rossing Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes Inception cohort study BMJ 328 2004 1105 1110
49. J.F. Mann, H.C. Gerstein, Q.L. Yi Development of renal disease in people at high cardiovascular risk Results of the HOPE randomized study J Am Soc Nephrol 14 2003 641 647
50. C.E. Buller, J.G. Nogareda, K. Ramanathan The profile of cardiac patients with renal artery stenosis J Am Coll Cardiol 43 2004 1606 1613
51. A. Levin, O. Djurdjev, B. Barrett Cardiovascular disease in patients with chronic kidney disease Getting to the heart of the matter Am J Kidney Dis 38 2001 1398 1407
52. W.M. McClellan, R.D. Langston, R. Presley Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease J Am Soc Nephrol 15 2004 1912 1919
53. M.J. Klag, P.K. Whelton, B.L. Randall Blood pressure and end-stage renal disease in men N Engl J Med 334 1996 13 18
54. F.L. Brancati, P.K. Whelton, B.L. Randall Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial JAMA 278 1997 2069 2074
55. M.K. Haroun, B.G. Jaar, S.C. Hoffman Risk factors for chronic kidney disease A prospective study of 23,534 men and women in Washington County, Maryland J Am Soc Nephrol 14 2003 2934 2941
56. J.H. Young, M.J. Klag, P. Muntner Blood pressure and decline in kidney function Findings from the Systolic Hypertension in the Elderly Program (SHEP) J Am Soc Nephrol 13 2002 2776 2782
57. S. Vupputuri, V. Batuman, P. Muntner Effect of blood pressure on early decline in kidney function among hypertensive men Hypertension 42 2003 1144 1149
58. E.S. Schaeffner, T. Kurth, G.C. Curhan Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091
59. P. Muntner, J. Coresh, J.C. Smith, J. Eckfeldt, M.J. Klag Plasma lipids and risk of developing renal dysfunction The Atherosclerosis Risk in Communities Study Kidney Int 58 2000 293 301
60. J. Segura, C. Campo, P. Gil Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients J Am Soc Nephrol 15 2004 1616 1622
61. C.S. Fox, M.G. Larson, E.P. Leip Predictors of new-onset kidney disease in a community-based population JAMA 291 2004 844 850
62. E.M. Briganti, P. Branley, S.J. Chadban Smoking is associated with renal impairment and proteinuria in the normal population: The AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study Am J Kidney Dis 40 2002 704 712
63. T. Chuahirun, D.E. Wesson Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition Am J Kidney Dis 39 2002 376 382
64. M. Regalado, S. Yang, D.E. Wesson Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension Am J Kidney Dis 35 2000 687 694
65. J. Chen, P. Muntner, L.L. Hamm The metabolic syndrome and chronic kidney disease in US adults Ann Intern Med 140 2004 167 174
66. E.L. Knight, E.B. Rimm, J.K. Pai Kidney dysfunction, inflammation, and coronary events A prospective study J Am Soc Nephrol 15 2004 1897 1903
67. M.G. Shlipak, L.F. Fried, C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 2003 87 92
68. E.M. Stuveling, H.L. Hillege, S.J. Bakker C-Reactive protein and microalbuminuria differ in their associations with various domains of vascular disease Atherosclerosis 172 2004 107 114
69. M.J. Sarnak, A. Poindexter, S.R. Wang Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study Kidney Int 62 2002 2208 2215
70. M.J. Sarnak, S.R. Wang, G.J. Beck Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression Am J Kidney Dis 40 2002 932 939
71. B.L. Kasiske Risk factors for accelerated atherosclerosis in renal transplant recipients Am J Med 84 1988 985 992
72. R.B. Himelman, J.S. Landzberg, J.S. Simonson Cardiac consequences of renal transplantation Changes in left ventricular morphology and function J Am Coll Cardiol 12 1988 915 923
73. A. Lindholm, D. Albrechtsen, L. Frodin Ischemic heart disease--Major cause of death and graft loss after renal transplantation in Scandinavia Transplantation 60 1995 451 457
74. J.M. Diaz, Z. Sainz, L.L. Guirado Risk factors for cardiovascular disease after renal transplantation Transplant Proc 35 2003 1722 1724
75. M. Varagunam, H. Finney, R. Trevitt Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients Am J Kidney Dis 43 2004 502 507
76. R.S. Bakri, B. Afzali, A. Covic Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation Clin Transplant 18 2004 201 204
77. C. Rigatto, P. Parfrey, R. Foley Congestive heart failure in renal transplant recipients Risk factors, outcomes, and relationship with ischemic heart disease J Am Soc Nephrol 13 2002 1084 1090
78. D. Ducloux, G. Motte, B. Challier, R. Gibey, J.M. Chalopin Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients A prospective study J Am Soc Nephrol 11 2000 134 137
79. K.C. Abbott, C.M. Yuan, A.J. Taylor, D.F. Cruess, L.Y. Agodoa Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression J Am Soc Nephrol 14 2003 2358 2365
80. G. Fernandez-Fresnedo, R. Escallada, E. Rodrigo The risk of cardiovascular disease associated with proteinuria in renal transplant patients Transplantation 73 2002 1345 1348
81. S. Baid-Agrawal, F.L. Delmonico, N.E. Tolkoff-Rubin Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients Transplantation 77 2004 1199 1202
82. K.C. Abbott, J.R. Bucci, D. Cruess, A.J. Taylor, L.Y. Agodoa Graft loss and acute coronary syndromes after renal transplantation in the United States J Am Soc Nephrol 13 2002 2560 2569
83. H. Holdaas, B. Fellstrom, A.G. Jardine Effect of fluvastatin on cardiac outcomes in renal transplant recipients A multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031
84. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril The HOPE randomized trial Ann Intern Med 134 2001 629 636
85. M. Tonelli, L. Moye, F.M. Sacks, B. Kiberd, G. Curhan Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency Ann Intern Med 138 2003 98 104
86. M. Tonelli, L. Moye, F.M. Sacks, T. Cole, G.C. Curhan Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 2003 1605 1613
87. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Am J Kidney Dis 41 suppl 3 2003 S1 S92
88. C. Baigent, M. Landry Study of Heart and Renal Protection (SHARP) Kidney Int 63 2003 207 210
89. M. Rao, B.J. Pereira Prospective trials on anemia of chronic disease The Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Kidney Int Suppl 87 2003 S12 S19
90. D.N. Reddan, A.K. Singh the CHOIR Study Group Can Risk Factor Modification Provide Meaningful Benefit? The Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) Study. Presented at: The American Society of Nephrology Renal Week. San Diego, CA, November 12-17 2003
91. I.C. Macdougall CREATE New strategies for early anaemia management in renal insufficiency Nephrol Dial Transplant 18 suppl 2 2003 Sii13 Sii6
92. G.F. Diercks, W.M. Janssen, A.J. van Boven Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]) Am J Cardiol 86 2000 635 638
93. H.I. Feldman, L.J. Appel, G.M. Chertow The Chronic Renal Insufficiency Cohort (CRIC) Study Design and methods J Am Soc Nephrol 14 suppl 2 2003 S148 S153